Skip to main content

ADVERTISEMENT

Jolynn Tumolo

News
11/03/2023
The Janus kinase (JAK) inhibitor upadacitinib offers a similar long-term safety profile across rheumatoid arthritis (RA), psoriatic arthritis (PsA), ankylosing spondylitis (AS), and atopic dermatitis (AD) despite some variations in adverse...
The Janus kinase (JAK) inhibitor upadacitinib offers a similar long-term safety profile across rheumatoid arthritis (RA), psoriatic arthritis (PsA), ankylosing spondylitis (AS), and atopic dermatitis (AD) despite some variations in adverse...
The Janus kinase (JAK) inhibitor...
11/03/2023
First Report Managed Care
News
03/06/2023
An investigation into how ketamine affects the brains of rats may lead to a better understanding of psychosis in people with schizophrenia.
An investigation into how ketamine affects the brains of rats may lead to a better understanding of psychosis in people with schizophrenia.
An investigation into how...
03/06/2023
Psych Congress Network
News
07/28/2023
This study analyzing data from patients with Parkinson disease (PD) psychosis showed that pimavanserin resulted in significantly lower rates of hospitalization than quetiapine.
This study analyzing data from patients with Parkinson disease (PD) psychosis showed that pimavanserin resulted in significantly lower rates of hospitalization than quetiapine.
This study analyzing data from...
07/28/2023
Annals of Long-Term Care
News
11/30/2022
Female college students whose parents provide them with alcohol engage in binge drinking more often than other students, according to a study presented at the recent American Psychiatric Nurses Association Annual Conference in Long Beach,...
Female college students whose parents provide them with alcohol engage in binge drinking more often than other students, according to a study presented at the recent American Psychiatric Nurses Association Annual Conference in Long Beach,...
Female college students whose...
11/30/2022
Addiction Professional
05/17/2016
Effects of forced vital capacity decline and suspected early acute idiopathic pulmonary fibrosis exacerbation on utilization and outcomes were recently discussed.
Effects of forced vital capacity decline and suspected early acute idiopathic pulmonary fibrosis exacerbation on utilization and outcomes were recently discussed.
Effects of forced vital capacity...
05/17/2016
First Report Managed Care
News
06/18/2021
“With proper training and education,” researchers wrote, “pharmacists are unique in improving vaccination services and public health in general.”
“With proper training and education,” researchers wrote, “pharmacists are unique in improving vaccination services and public health in general.”
“With proper training and...
06/18/2021
Pharmacy Learning Network
News
07/26/2021
According to study findings, weekly dance training stalled the progression of motor and nonmotor symptoms over 3 years in a small group of patients with mild to moderate Parkinson disease.
According to study findings, weekly dance training stalled the progression of motor and nonmotor symptoms over 3 years in a small group of patients with mild to moderate Parkinson disease.
According to study findings,...
07/26/2021
Annals of Long-Term Care
News
08/26/2021
The FDA has issued a Class II recall for more than 37,000 bottles of a prescription medication used to treat muscle spasms.
The FDA has issued a Class II recall for more than 37,000 bottles of a prescription medication used to treat muscle spasms.
The FDA has issued a Class II...
08/26/2021
Pharmacy Learning Network
News
09/23/2021
Rhodes Pharmaceuticals is recalling oxycodone hydrochloride tablets because a hydrochlorothiazide-lisinopril tablet was found in a bottle.
Rhodes Pharmaceuticals is recalling oxycodone hydrochloride tablets because a hydrochlorothiazide-lisinopril tablet was found in a bottle.
Rhodes Pharmaceuticals is...
09/23/2021
Pharmacy Learning Network
News
10/19/2021
Six weeks of daily lumateperone significantly improved depressive symptoms in patients with bipolar disorder experiencing a major depressive episode, study finds.
Six weeks of daily lumateperone significantly improved depressive symptoms in patients with bipolar disorder experiencing a major depressive episode, study finds.
Six weeks of daily lumateperone...
10/19/2021
Psychiatry & Behavioral Health